Hepatitis C virus (HCV) infection is frequent among kidney transplant recipients and it is currently the major cause of chronic liver disease following kidney transplantation. Current article summarizes our current understanding of the epidemiology and management of HCV infection in kidney transplant recipients. The prevalence of HCV infection in kidney transplant recipients is significantly higher than in the general population and it is associated with increased morbidity and mortality. End stage renal disease patients are treated with kidney transplantation.
Major complications that arise after kidney transplantation are associated with Hepatitis C affected liver complications. Hepatitis C infections are becoming common among end-stage kidney transplants. The mortality in HCV-infected patients was 3 times more than that in normal transplanted patients not infected. Approximately 40%…
